A comprehensive view of Cysts / Lesions / Tumors. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AbbVie to acquire ImmunoGen for US$10.1B, including its flagship cancer therapy Elahere mirvetuximab soravtansine-gynx, expanding its solid tumor portfolio; Elahere is a first-in-class antibody-drug conjugate approved for platinum-resistant ovarian cancer

Novartis pays US$100.0M to Legend Biosciences for selection of solid-tumor-focused cell therapies; Novartis to manufacture the drugs using its T-Charge platform

Daiichi Sankyo and Merck announce global development and commercialization collaboration for three Daiichi Sankyo DXd ADCs under development to treat multiple solid tumors; Merck to pay Daiichi Sankyo US$4.0B upfront in deal worth up to US$16.5B

BioNTech to present clinical and preclinical data updates across multiple immuno-oncology programs at 2023 SITC Annual Meeting in San Diego, California, from November 1-5

BioNTech presents positive Phase 1/2 data update for CAR-T cell therapy candidate BNT211 in advanced solid tumors at ESMO Congress 2023; the therapy combines BioNTech's CAR-T and FixVac platform technologies

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count